In the present study, we address the protein expression of TLR7 and TLR9 determined by ELISA methods, in addition to the modifications found in the renal and rheumatological functions of recently diagnosed Class III and Class IV LN patients at 12 months of follow-up. Here, TLR9 is linked to lobular neoplasia.